These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation. Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430 [TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells. Holmøy T; Fredriksen AB; Thompson KM; Hestvik AL; Bogen B; Vartdal F Eur J Immunol; 2005 Jun; 35(6):1786-94. PubMed ID: 15864781 [TBL] [Abstract][Full Text] [Related]
5. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366 [TBL] [Abstract][Full Text] [Related]
6. The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution. Beseler C; Vollmer T; Graner M; Yu X PLoS One; 2017; 12(10):e0186842. PubMed ID: 29059249 [TBL] [Abstract][Full Text] [Related]
7. T cells recognizing multiple peptides of myelin basic protein are found in blood and enriched in cerebrospinal fluid in optic neuritis and multiple sclerosis. Söderström M; Link H; Sun JB; Fredrikson S; Kostulas V; Höjeberg B; Li BL; Olsson T Scand J Immunol; 1993 Mar; 37(3):355-68. PubMed ID: 7680141 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases. Rawes JA; Calabrese VP; Khan OA; DeVries GH Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635 [TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis is associated with enhanced B cell responses to the ganglioside GD1a. Matà S; Lolli F; Söderström M; Pinto F; Link H Mult Scler; 1999 Dec; 5(6):379-88. PubMed ID: 10618693 [TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187 [TBL] [Abstract][Full Text] [Related]
11. Autoreactive T and B cells in nervous system diseases. Sun JB Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894 [TBL] [Abstract][Full Text] [Related]
12. IgM, IgA and IgG producing cells in cerebrospinal fluid and peripheral blood in multiple sclerosis. Henriksson A; Kam-Hansen S; Link H Clin Exp Immunol; 1985 Oct; 62(1):176-84. PubMed ID: 4064372 [TBL] [Abstract][Full Text] [Related]
13. T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders. Pirttilä T; Antonen J; Syrjälä P; Frey H Ann N Y Acad Sci; 1987; 496():691-6. PubMed ID: 3496834 [TBL] [Abstract][Full Text] [Related]
14. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688 [TBL] [Abstract][Full Text] [Related]
15. CD4 T cell activation and disease activity at onset of multiple sclerosis. Jensen J; Langkilde AR; Fenst C; Nicolaisen MS; Roed HG; Christiansen M; Sellebjerg F J Neuroimmunol; 2004 Apr; 149(1-2):202-9. PubMed ID: 15020081 [TBL] [Abstract][Full Text] [Related]